177 related articles for article (PubMed ID: 18478853)
21. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
22. PET and PET-CT in esophageal and gastric cancer.
Wieder HA; Krause BJ; Herrmann K
Methods Mol Biol; 2011; 727():59-76. PubMed ID: 21331929
[TBL] [Abstract][Full Text] [Related]
23. Role of positron emission tomography in staging esophageal cancer.
Luketich JD; Schauer PR; Meltzer CC; Landreneau RJ; Urso GK; Townsend DW; Ferson PF; Keenan RJ; Belani CP
Ann Thorac Surg; 1997 Sep; 64(3):765-9. PubMed ID: 9307471
[TBL] [Abstract][Full Text] [Related]
24. [A proposal for the rational use of the PET in oncology].
Borrego Dorado I; Vázquez Albertino R
Rev Esp Med Nucl; 2002 May; 21(3):163-73. PubMed ID: 12206749
[TBL] [Abstract][Full Text] [Related]
25. The value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancer.
Rankin S
Cancer Imaging; 2011 Oct; 11 Spec No A(1A):S156-60. PubMed ID: 22186083
[TBL] [Abstract][Full Text] [Related]
26. PET and PET-CT for evaluation of colorectal carcinoma.
Delbeke D; Martin WH
Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
Czech N; Brenner W; Kampen WU; Henze E
Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
[No Abstract] [Full Text] [Related]
28. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
Lonneux M; Reffad AM; Detry R; Kartheuser A; Gigot JF; Pauwels S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):915-21. PubMed ID: 12111132
[TBL] [Abstract][Full Text] [Related]
29. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Laurens ST; Oyen WJ
PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
[TBL] [Abstract][Full Text] [Related]
30. Clinical applications of PET in oncology.
Rohren EM; Turkington TG; Coleman RE
Radiology; 2004 May; 231(2):305-32. PubMed ID: 15044750
[TBL] [Abstract][Full Text] [Related]
31. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer.
Valk PE; Abella-Columna E; Haseman MK; Pounds TR; Tesar RD; Myers RW; Greiss HB; Hofer GA
Arch Surg; 1999 May; 134(5):503-11; discussion 511-3. PubMed ID: 10323422
[TBL] [Abstract][Full Text] [Related]
32. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Watson AJ; Lolohea S; Robertson GM; Frizelle FA
Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
[TBL] [Abstract][Full Text] [Related]
33. Impact of FDG-PET for staging of oesophageal cancer.
Imdahl A; Hentschel M; Kleimaier M; Hopt UT; Brink I
Langenbecks Arch Surg; 2004 Aug; 389(4):283-8. PubMed ID: 15197549
[TBL] [Abstract][Full Text] [Related]
34. Where can FDG-PET contribute most to anatomical imaging problems?
Bingham JB
Br J Radiol; 2002 Nov; 75 Spec No():S39-52. PubMed ID: 12519735
[No Abstract] [Full Text] [Related]
35. The role of positron emission tomography in the management of colorectal cancer.
Tutt AN; Plunkett TA; Barrington SF; Leslie MD
Colorectal Dis; 2004 Jan; 6(1):2-9. PubMed ID: 14692944
[TBL] [Abstract][Full Text] [Related]
36. Emerging role of PET in the diagnosis and staging of lung cancer.
Coates G; Skehan SJ
Can Respir J; 1999; 6(2):145-52. PubMed ID: 10322097
[TBL] [Abstract][Full Text] [Related]
37. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
[TBL] [Abstract][Full Text] [Related]
38. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Delbeke D
J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218
[TBL] [Abstract][Full Text] [Related]
39. [18F-fluorodeoxyglucose positron emission tomography in colorectal cancer: value in primary staging and follow-up].
Jörg L; Heinisch M; Rechberger E; Kurz F; Klug R; Aufschnaiter M; Hammer J; Langsteger W
Acta Med Austriaca; 2002; 29(5):176-9. PubMed ID: 12506769
[TBL] [Abstract][Full Text] [Related]
40. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.
Bury T; Corhay JL; Duysinx B; Daenen F; Ghaye B; Barthelemy N; Rigo P; Bartsch P
Eur Respir J; 1999 Dec; 14(6):1376-80. PubMed ID: 10624770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
